Early and locally advanced breast cancer: diagnosis and management

Supporting evidence

• Evidence review

• Evidence reviews

• O: Non-pharmacological prevention of lymphoedema in people who have, or have had, breast cancer (PDF 1.42 MB)

  Published:

  19 February 2025

• P: Non-pharmacological management of lymphoedema in people who have, or have had, breast cancer (PDF 3.28 MB)

  Published:

  19 February 2025

• N: Further surgery after breast-conserving surgery based on tissue margins (PDF 2.48 MB)

  Published:

  16 January 2024

• M: Effectiveness of different external beam hypofractionation radiotherapy regimens in people with early-stage or locally advanced invasive breast cancer (PDF 2.02 MB)

  Published:

  14 June 2023

• L: Strategies for reducing arm and shoulder problems after breast cancer surgery or radiotherapy (PDF 5.02 MB)

  Published:

  05 April 2023

• A: Surgery to the breast (PDF 1.07 MB)

  Published:

  18 July 2018

• B: Management of positive axilla  (PDF 2.11 MB)

  Published:

  18 July 2018

• C: Adjuvant systemic therapy planning (PDF 1.21 MB)

  Published:

  18 July 2018

• D: Endocrine therapy (PDF 2.2 MB)

  Published:

  18 July 2018

• E: Adjuvant chemotherapy (PDF 4.78 MB)

  Published:

  18 July 2018

• F: Adjuvant biological therapy (PDF 1.43 MB)

  Published:

  18 July 2018

• G: Adjuvant bisphosphonates (PDF 2.45 MB)

  Published:

  18 July 2018

• H: Breast radiotherapy (PDF 2.23 MB)

  Published:

  18 July 2018

• I: Postmastectomy radiotherapy (PDF 3.75 MB)

  Published:

  18 July 2018

• J: Neoadjuvant treatment (PDF 2.82 MB)

  Published:

  18 July 2018

• K: Lifestyle (PDF 781 KB)

  Published:

  18 July 2018

• Evidence review (PDF 10.61 MB)

  Published:

  25 February 2009

• Surveillance report

• 2023 surveillance of early and locally advanced breast cancer: diagnosis and management (NICE guideline NG101) and advanced breast cancer: diagnosis and treatment (NICE guideline CG81)

• Appendix A: Summary of evidence from surveillance (PDF 1.1 MB)

  Published:

  12 January 2023

• Appendix B: Equality and health inequalities assessment (PDF 173 KB)

  Published:

  12 January 2023

• 2022 exceptional surveillance of early and locally advanced breast cancer: diagnosis and management (NICE guideline NG101)

• Appendix A: Summary details of included studies (PDF 109 KB)

  Published:

  11 August 2022

• 2022 exceptional surveillance of early and locally advanced breast cancer: diagnosis and management (NICE guideline NG101)

• 2022 exceptional surveillance of early and locally advanced breast cancer: diagnosis and management (NICE guideline NG101)

• 2020 exceptional surveillance of early and locally advanced breast cancer: diagnosis and management (NICE guideline NG101)

• Appendix A: Summary of evidence from surveillance (PDF 514 KB)

  Published:

  09 June 2020

• Surveillance review decision (NICE guideline CG80) - November 2015 (PDF 233 KB)

  Published:

  18 November 2015

• Surveillance review decision matrix (NICE guideline CG80) - November 2015 (PDF 547 KB)

  Published:

  18 November 2015

• Other supporting evidence

• Methods - February 2025 (PDF 235 KB)

  Published:

  19 February 2025

• Methods - July 2018 (PDF 424 KB)

  Published:

  18 July 2018

• Supplement 1 - Health economics (PDF 393 KB)

  Published:

  18 July 2018

• Supplement 2 - NGA staff, glossary, abbreviations and equalities considerations (PDF 784 KB)

  Published:

  18 July 2018

• Supplement 3 - Algorithm (PDF 303 KB)

  Published:

  18 July 2018

• Full guidance

• Full guideline – February 2009

• Full guideline (PDF 2.96 MB)

  Published:

  25 February 2009